Evidence-based clinical practice guidelines for inflammatory bowel disease-Reference-Cited by-同舟云学术

Evidence-based clinical practice guidelines for inflammatory bowel disease

Published:2018-02-10 Issue:3 Volume:53 Page:305-353
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Matsuoka Katsuyoshi,Kobayashi Taku,Ueno Fumiaki,Matsui Toshiyuki,Hirai Fumihito,Inoue Nagamu,Kato Jun,Kobayashi Kenji,Kobayashi Kiyonori,Koganei Kazutaka,Kunisaki Reiko,Motoya Satoshi,Nagahori Masakazu,Nakase Hiroshi,Omata Fumio,Saruta Masayuki,Watanabe Toshiaki,Tanaka Toshiaki,Kanai Takanori,Noguchi Yoshinori,Takahashi Ken-ichi,Watanabe Kenji,Hibi Toshifumi,Suzuki Yasuo,Watanabe Mamoru,Sugano Kentaro,Shimosegawa Tooru

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-018-1439-1/fulltext.html

Reference316 articles.

1. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105(3):501–23 (quiz 24. Epub 2010/01/14).

2. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104(2):465–83 (quiz 4, 84. Epub 2009/01/29).

3. Japan Intractable Diseases Information Center. http://www.nanbyou.or.jp .

4. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–24 (Epub 2012/11/07).

5. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11(2):154–63 (Epub 2005/01/29).

Cited by 388 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary Porphyra tenera ameliorated dextran sodium sulfate-induced colitis in mice via modulating gut microbiota dysbiosis;Food Chemistry;2024-12

2. Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection;Cureus;2024-09-03

3. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model;ACS Pharmacology & Translational Science;2024-08-30

4. Enhanced anti-inflammatory activity of chlorogenic acid via folic acid-TPGS-modified liposomes encapsulation: characterization and In vivo evaluation on colitis mice;Frontiers in Pharmacology;2024-08-23

5. Nutrigenomics in Autoimmune Disease;Advances in Medical Diagnosis, Treatment, and Care;2024-08-09